Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Rhythm Pharmaceuticals Inc | RYTM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 39.71 | 04:01:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 39.71 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 15.5001 - 52.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 39.71 | USD |
Rhythm Pharmaceuticals (RYTM) Options Flow Summary
Rhythm Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.39B | 60.14M | - | 77.43M | -184.68M | -3.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Rhythm Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RYTM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 37.83 | 41.85 | 36.92 | 38.87 | 451,476 | 1.88 | 4.97% |
| 1 Month | 42.54 | 43.68 | 36.92 | 40.51 | 522,544 | -2.83 | -6.65% |
| 3 Months | 44.65 | 52.57 | 36.92 | 43.15 | 581,253 | -4.94 | -11.06% |
| 6 Months | 22.02 | 52.57 | 21.63 | 40.34 | 671,841 | 17.69 | 80.34% |
| 1 Year | 20.42 | 52.57 | 15.5001 | 30.27 | 684,258 | 19.29 | 94.47% |
| 3 Years | 20.57 | 52.57 | 3.04 | 19.92 | 755,867 | 19.14 | 93.05% |
| 5 Years | 25.15 | 52.57 | 3.04 | 20.73 | 567,581 | 14.56 | 57.89% |
Rhythm Pharmaceuticals Description
| Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. |
